ZINC CHLORIDE

ZINC CHLORIDE was reported 25334 times

ZINC CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 54 0.7714
1 RADIATION INFLAMMATION 28 0.3500
2 COPPER DEFICIENCY 25 0.2083
3 VAGINAL FLATULENCE 43 0.1419
4 SEDATION COMPLICATION 316 0.1237
5 PRODUCT ADMINISTRATION ISSUE 21 0.1005
6 RHINOCEREBRAL MUCORMYCOSIS 30 0.0865
7 MULTIPLE DRUG THERAPY 61 0.0809
8 CREATININE RENAL CLEARANCE DECREASED 323 0.0806
9 CARBUNCLE 21 0.0742
10 APPENDICOLITH 27 0.0698
11 CREATININE RENAL CLEARANCE INCREASED 51 0.0682
12 NECROSIS ISCHAEMIC 21 0.0456
13 FEMALE GENITAL TRACT FISTULA 65 0.0380
14 PULMONARY PAIN 109 0.0373
15 BLOOD CALCIUM DECREASED 360 0.0320
16 SINUSITIS FUNGAL 25 0.0312
17 GENITAL ULCERATION 22 0.0286
18 FACET JOINT SYNDROME 92 0.0282
19 MONOCLONAL IMMUNOGLOBULIN PRESENT 21 0.0276
20 PERIPHERAL VENOUS DISEASE 110 0.0269
21 ONYCHOMYCOSIS 115 0.0262
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
23 CHRONIC SINUSITIS 85 0.0226
24 ONYCHOMADESIS 95 0.0226
25 RHEUMATIC FEVER 100 0.0224
26 FINGER DEFORMITY 108 0.0223
27 INFUSION SITE DISCHARGE 39 0.0222
28 ORTHOSTATIC HYPOTENSION 355 0.0204
29 PNEUMONIA STREPTOCOCCAL 22 0.0201
30 RADICULOPATHY 49 0.0186
31 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 23 0.0183
32 RENAL FUNCTION TEST ABNORMAL 83 0.0179
33 HYPOTHALAMO-PITUITARY DISORDER 26 0.0178
34 SINUS PAIN 41 0.0176
35 MACROCYTOSIS 20 0.0172
36 CONGENITAL ANOMALY 130 0.0168
37 PRODUCT LABEL CONFUSION 97 0.0166
38 PROCTITIS 46 0.0164
39 GENITAL PAIN 24 0.0162
40 BLEPHAROSPASM 97 0.0154
41 INFUSION SITE BRUISING 33 0.0153
42 BREAST CANCER STAGE III 91 0.0140
43 NAIL DISORDER 119 0.0136
44 MUSCLE INJURY 111 0.0134
45 SEDATION 350 0.0134
46 TOTAL LUNG CAPACITY DECREASED 21 0.0131
47 GENITAL HERPES 20 0.0131
48 C-REACTIVE PROTEIN ABNORMAL 82 0.0128
49 SPUTUM INCREASED 27 0.0125
50 HAEMORRHAGIC DIATHESIS 44 0.0123
51 EYELID PAIN 25 0.0123
52 ENDOMETRIAL CANCER 27 0.0123
53 SEASONAL ALLERGY 173 0.0122
54 MACULAR DEGENERATION 142 0.0119
55 WOUND INFECTION 130 0.0119
56 WOUND SECRETION 45 0.0115
57 PARANASAL SINUS DISCOMFORT 43 0.0113
58 RESPIRATORY SYMPTOM 32 0.0112
59 LIP DRY 102 0.0112
60 GRIP STRENGTH DECREASED 98 0.0111
61 INFUSION SITE PRURITUS 35 0.0111
62 EAR CONGESTION 30 0.0111
63 OBESITY 175 0.0110
64 INFUSION SITE HAEMORRHAGE 36 0.0109
65 HYPERCHOLESTEROLAEMIA 104 0.0108
66 DIASTOLIC DYSFUNCTION 33 0.0107
67 BLADDER SPASM 20 0.0107
68 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 76 0.0106
69 NASAL POLYPS 52 0.0105
70 TASTE DISORDER 213 0.0105
71 BACK INJURY 114 0.0105
72 APLASTIC ANAEMIA 54 0.0103
73 HYPERPHOSPHATAEMIA 22 0.0102
74 DUODENAL ULCER PERFORATION 76 0.0102
75 LIVE BIRTH 83 0.0099
76 ARTHRITIS INFECTIVE 46 0.0099
77 JOINT RANGE OF MOTION DECREASED 133 0.0099
78 COGNITIVE DISORDER 458 0.0098
79 SKIN ATROPHY 56 0.0097
80 BLOOD PHOSPHORUS INCREASED 26 0.0095
81 NEUROLOGICAL DECOMPENSATION 22 0.0095
82 HELICOBACTER INFECTION 97 0.0094
83 WOUND COMPLICATION 32 0.0093
84 BURSITIS 110 0.0091
85 FOLLICULITIS 95 0.0091
86 MULTIPLE ALLERGIES 71 0.0090
87 DEPRESSED LEVEL OF CONSCIOUSNESS 356 0.0090
88 COELIAC DISEASE 88 0.0090
89 INFUSION SITE SWELLING 56 0.0089
90 SKIN LACERATION 95 0.0087
91 MOBILITY DECREASED 618 0.0086
92 APPETITE DISORDER 57 0.0086
93 SKIN WARM 50 0.0086
94 FIBROSIS 26 0.0084
95 ORAL CANDIDIASIS 110 0.0083
96 FOOD POISONING 43 0.0080
97 LUNG OPACITY 21 0.0080
98 SKIN ODOUR ABNORMAL 31 0.0079
99 ABDOMINAL MASS 21 0.0078
100 PARAESTHESIA ORAL 112 0.0078
101 INFUSION SITE REACTION 23 0.0077
102 INFUSION SITE PAIN 98 0.0076
103 IRRITABLE BOWEL SYNDROME 163 0.0076
104 BALANCE DISORDER 657 0.0076
105 SUSPECTED COVID-19 25 0.0076
106 ABNORMAL FAECES 62 0.0076
107 OSTEOARTHRITIS 319 0.0075
108 SPINAL STENOSIS 31 0.0075
109 HAND DEFORMITY 98 0.0075
110 AORTIC STENOSIS 26 0.0075
111 AMMONIA INCREASED 38 0.0074
112 PEMPHIGUS 93 0.0074
113 TENDERNESS 77 0.0074
114 BRAIN FOG 115 0.0073
115 VITAMIN B12 DECREASED 21 0.0073
116 BLOOD URIC ACID INCREASED 42 0.0073
117 BLADDER PAIN 23 0.0072
118 SYNOVITIS 130 0.0072
119 EPIGASTRIC DISCOMFORT 28 0.0072
120 WOUND 200 0.0071
121 PROSTATOMEGALY 28 0.0071
122 VULVOVAGINAL DRYNESS 23 0.0071
123 TUMOUR MARKER INCREASED 34 0.0071
124 PARANASAL SINUS HYPERSECRETION 27 0.0071
125 RALES 41 0.0071
126 INSURANCE ISSUE 107 0.0070
127 EYELID MARGIN CRUSTING 20 0.0069
128 IRON DEFICIENCY 31 0.0069
129 OVERWEIGHT 37 0.0069
130 EAR PAIN 133 0.0068
131 FIBROMYALGIA 165 0.0068
132 INFUSION SITE ERYTHEMA 57 0.0068
133 LOWER RESPIRATORY TRACT INFECTION 307 0.0067
134 BODY HEIGHT DECREASED 72 0.0067
135 SKIN PAPILLOMA 27 0.0067
136 VASCULAR DEVICE INFECTION 30 0.0066
137 POLYMYALGIA RHEUMATICA 21 0.0066
138 SINUS DISORDER 129 0.0065
139 ADVERSE REACTION 86 0.0065
140 SCIATICA 103 0.0065
141 KNEE ARTHROPLASTY 135 0.0064
142 BRONCHIECTASIS 43 0.0064
143 MYASTHENIA GRAVIS 51 0.0063
144 NIGHT SWEATS 202 0.0063
145 ANAL INCONTINENCE 56 0.0062
146 GLOSSITIS 22 0.0062
147 DYSPHORIA 31 0.0061
148 LIVER FUNCTION TEST INCREASED 131 0.0061
149 LYMPHOEDEMA 42 0.0061
150 PERICARDITIS 102 0.0061
151 UPPER-AIRWAY COUGH SYNDROME 50 0.0061
152 PHOTOPHOBIA 114 0.0061
153 ARTHROPATHY 336 0.0060
154 DYSLIPIDAEMIA 30 0.0059
155 SARS-COV-2 TEST POSITIVE 78 0.0059
156 PRODUCT ADMINISTRATION INTERRUPTED 46 0.0059
157 HYPOPHOSPHATAEMIA 43 0.0058
158 HIDRADENITIS 53 0.0058
159 ROSACEA 27 0.0058
160 HIATUS HERNIA 75 0.0058
161 INTERVERTEBRAL DISC DEGENERATION 53 0.0057
162 GAIT INABILITY 191 0.0057
163 SENSITIVE SKIN 42 0.0057
164 ORAL PAIN 127 0.0057
165 BLOOD IRON DECREASED 67 0.0056
166 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
167 VAGINAL DISCHARGE 57 0.0056
168 SINUSITIS 576 0.0056
169 PAROSMIA 42 0.0056
170 LIMB INJURY 151 0.0056
171 COVID-19 972 0.0055
172 RENAL CYST 44 0.0055
173 MENISCUS INJURY 34 0.0055
174 NORMAL NEWBORN 30 0.0055
175 NECK PAIN 306 0.0055
176 SPINAL OSTEOARTHRITIS 48 0.0055
177 OESOPHAGEAL DISORDER 21 0.0054
178 FUNGAL SKIN INFECTION 22 0.0054
179 BLOOD MAGNESIUM DECREASED 47 0.0054
180 BLOOD CHOLESTEROL INCREASED 252 0.0054
181 GLOSSODYNIA 121 0.0054
182 HYPOAESTHESIA ORAL 81 0.0054
183 EXOSTOSIS 49 0.0054
184 DIZZINESS POSTURAL 52 0.0054
185 BLOOD CALCIUM INCREASED 47 0.0054
186 IMPAIRED HEALING 175 0.0053
187 HORDEOLUM 23 0.0053
188 SNEEZING 119 0.0053
189 CONSTIPATION 1155 0.0053
190 GASTROINTESTINAL PAIN 58 0.0053
191 DERMATITIS CONTACT 60 0.0053
192 LIVER INJURY 129 0.0053
193 CANDIDA INFECTION 88 0.0052
194 HERPES VIRUS INFECTION 30 0.0052
195 MUSCLE STRAIN 45 0.0052
196 TONGUE DISCOMFORT 22 0.0052
197 COVID-19 PNEUMONIA 61 0.0052
198 TENDON PAIN 39 0.0051
199 IRON DEFICIENCY ANAEMIA 47 0.0051
200 NEURALGIA 123 0.0051
201 FOOD ALLERGY 39 0.0050
202 FOOT DEFORMITY 56 0.0050
203 HAEMOGLOBIN INCREASED 23 0.0050
204 BLADDER DISORDER 50 0.0050
205 AUTOIMMUNE THYROIDITIS 19 0.0050
206 EAR DISORDER 23 0.0050
207 ATTENTION DEFICIT HYPERACTIVITY DISORDER 21 0.0050
208 RESPIRATORY TRACT CONGESTION 79 0.0050
209 WEIGHT FLUCTUATION 52 0.0050
210 DYSSTASIA 145 0.0050
211 SWELLING OF EYELID 31 0.0049
212 SINUS CONGESTION 66 0.0049
213 SLEEP DISORDER 342 0.0048
214 WHEEZING 287 0.0048
215 FULL BLOOD COUNT DECREASED 97 0.0048
216 PRE-EXISTING CONDITION IMPROVED 30 0.0048
217 INFUSION RELATED REACTION 318 0.0048
218 DRY MOUTH 387 0.0048
219 FREQUENT BOWEL MOVEMENTS 128 0.0047
220 JOINT STIFFNESS 124 0.0047
221 THINKING ABNORMAL 88 0.0047
222 BLISTER 265 0.0047
223 CARPAL TUNNEL SYNDROME 66 0.0047
224 INFLAMMATION 243 0.0047
225 EXERCISE TOLERANCE DECREASED 27 0.0047
226 PSORIATIC ARTHROPATHY 190 0.0047
227 PSEUDOMONAS INFECTION 40 0.0047
228 HEPATIC ENCEPHALOPATHY 43 0.0046
229 APPENDICITIS 43 0.0046
230 STOMATITIS 279 0.0046
231 VITAMIN D DECREASED 39 0.0046
232 DYSPHEMIA 20 0.0046
233 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219 0.0046
234 MICTURITION URGENCY 52 0.0045
235 LIGAMENT SPRAIN 45 0.0045
236 POST PROCEDURAL INFECTION 37 0.0045
237 WALKING AID USER 30 0.0045
238 TYPE 2 DIABETES MELLITUS 153 0.0045
239 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23 0.0045
240 FAECES SOFT 33 0.0045
241 LIGAMENT RUPTURE 20 0.0045
242 GASTROOESOPHAGEAL REFLUX DISEASE 364 0.0045
243 SYMPTOM RECURRENCE 27 0.0045
244 VITAMIN D DEFICIENCY 44 0.0045
245 WRIST FRACTURE 54 0.0045
246 HOT FLUSH 339 0.0045
247 ABDOMINAL DISTENSION 469 0.0045
248 MUSCULOSKELETAL STIFFNESS 393 0.0045
249 YELLOW SKIN 21 0.0045
250 SECRETION DISCHARGE 56 0.0045
251 INCREASED TENDENCY TO BRUISE 41 0.0045
252 JOINT INJURY 95 0.0044
253 SPINAL PAIN 52 0.0044
254 FAILURE TO THRIVE 23 0.0044
255 PERIORBITAL SWELLING 25 0.0044
256 OBSTRUCTIVE AIRWAYS DISORDER 49 0.0044
257 BLOOD POTASSIUM DECREASED 132 0.0044
258 BLOOD TESTOSTERONE DECREASED 30 0.0044
259 JAW DISORDER 24 0.0044
260 SCAR 75 0.0044
261 GASTROENTERITIS VIRAL 79 0.0044
262 POLYARTHRITIS 23 0.0044
263 RHINORRHOEA 282 0.0044
264 EMPHYSEMA 44 0.0044
265 FULL BLOOD COUNT ABNORMAL 46 0.0043
266 GOUT 78 0.0043
267 EYE INFECTION 49 0.0043
268 CARDIAC FLUTTER 28 0.0043
269 DYSPEPSIA 426 0.0043
270 PROCEDURAL PAIN 120 0.0043
271 PRODUCT DISTRIBUTION ISSUE 40 0.0043
272 LUNG DISORDER 211 0.0043
273 OCULAR DISCOMFORT 48 0.0043
274 EYE PAIN 240 0.0042
275 HYPERVOLAEMIA 21 0.0042
276 DIABETIC NEUROPATHY 21 0.0042
277 DIVERTICULUM 30 0.0042
278 PERIPHERAL SWELLING 649 0.0042
279 OROPHARYNGEAL DISCOMFORT 38 0.0042
280 NOCTURIA 51 0.0042
281 SLEEP APNOEA SYNDROME 80 0.0042
282 HEAD DISCOMFORT 74 0.0042
283 MIGRAINE 399 0.0042
284 PROCEDURAL COMPLICATION 32 0.0042
285 DECUBITUS ULCER 34 0.0042
286 NASAL DRYNESS 26 0.0041
287 GINGIVAL PAIN 33 0.0041
288 SKIN FISSURES 81 0.0041
289 THIRST 74 0.0041
290 UPPER RESPIRATORY TRACT INFECTION 191 0.0041
291 THERAPEUTIC PRODUCT EFFECT DECREASED 185 0.0041
292 PRODUCTIVE COUGH 197 0.0041
293 SCAB 47 0.0041
294 EAR DISCOMFORT 42 0.0041
295 POOR QUALITY SLEEP 88 0.0041
296 POLLAKIURIA 170 0.0041
297 TROPONIN INCREASED 31 0.0041
298 DECREASED INTEREST 24 0.0041
299 PURPURA 36 0.0041
300 PRODUCT DOSE OMISSION IN ERROR 115 0.0041
301 RED BLOOD CELL COUNT DECREASED 116 0.0041
302 MUSCULAR WEAKNESS 461 0.0041
303 MUSCLE SPASMS 744 0.0041
304 SINUS HEADACHE 24 0.0040
305 BRONCHITIS 299 0.0040
306 CONTUSION 388 0.0040
307 SYSTEMIC LUPUS ERYTHEMATOSUS 143 0.0040
308 FEELING COLD 112 0.0040
309 EAR INFECTION 107 0.0040
310 HYPERAESTHESIA 33 0.0040
311 SKIN DISORDER 133 0.0040
312 ERUCTATION 77 0.0040
313 DYSPNOEA EXERTIONAL 149 0.0040
314 ILLNESS 407 0.0039
315 HEART RATE ABNORMAL 22 0.0039
316 RETCHING 84 0.0039
317 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
318 ONYCHOCLASIS 27 0.0039
319 FACIAL PAIN 35 0.0039
320 BOWEL MOVEMENT IRREGULARITY 30 0.0039
321 BLOOD TEST ABNORMAL 55 0.0039
322 ARTHROPOD BITE 29 0.0039
323 BACTERIAL INFECTION 73 0.0039
324 ORAL HERPES 76 0.0039
325 PHARYNGEAL SWELLING 38 0.0039
326 HIP SURGERY 21 0.0039
327 FLATULENCE 220 0.0039
328 THROAT IRRITATION 174 0.0039
329 VARICOSE VEIN 20 0.0039
330 PRODUCT USE COMPLAINT 61 0.0039
331 APHTHOUS ULCER 30 0.0039
332 RENAL PAIN 41 0.0039
333 THERAPY CHANGE 38 0.0039
334 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 21 0.0039
335 FALL 1278 0.0038
336 HEPATIC ENZYME INCREASED 261 0.0038
337 TENDONITIS 59 0.0038
338 FUNGAL INFECTION 127 0.0038
339 OXYGEN SATURATION DECREASED 214 0.0038
340 URINARY TRACT INFECTION 649 0.0038
341 INITIAL INSOMNIA 39 0.0038
342 NASOPHARYNGITIS 700 0.0038
343 NASAL CONGESTION 223 0.0038
344 PRODUCT FORMULATION ISSUE 25 0.0038
345 IMPAIRED QUALITY OF LIFE 54 0.0038
346 HEPATITIS 96 0.0037
347 MUSCULOSKELETAL CHEST PAIN 58 0.0037
348 MUSCLE SPASTICITY 46 0.0037
349 AGEUSIA 93 0.0037
350 OROPHARYNGEAL PAIN 345 0.0037
351 RESPIRATORY TRACT INFECTION 97 0.0037
352 PERIPHERAL COLDNESS 51 0.0037
353 SCOLIOSIS 23 0.0037
354 MUSCLE ATROPHY 47 0.0037
355 BRUXISM 20 0.0037
356 PNEUMONIA BACTERIAL 34 0.0037
357 MUSCLE TIGHTNESS 60 0.0037
358 PYELONEPHRITIS 32 0.0037
359 ALOPECIA 725 0.0037
360 RESTLESS LEGS SYNDROME 67 0.0037
361 SENSATION OF FOREIGN BODY 31 0.0037
362 DRY EYE 183 0.0037
363 MALNUTRITION 41 0.0037
364 PSYCHIATRIC SYMPTOM 27 0.0037
365 COUGH 1023 0.0036
366 SQUAMOUS CELL CARCINOMA OF SKIN 22 0.0036
367 ASTHENOPIA 20 0.0036
368 ABDOMINAL DISCOMFORT 610 0.0036
369 SLUGGISHNESS 37 0.0036
370 DENTAL CARIES 40 0.0036
371 DECREASED ACTIVITY 39 0.0036
372 URINARY INCONTINENCE 107 0.0036
373 FOREIGN BODY SENSATION IN EYES 23 0.0036
374 MUSCULOSKELETAL DISCOMFORT 62 0.0036
375 FEEDING DISORDER 73 0.0036
376 SALIVARY HYPERSECRETION 36 0.0036
377 EPILEPSY 110 0.0036
378 DISEASE RECURRENCE 171 0.0036
379 SWELLING 336 0.0036
380 MEMORY IMPAIRMENT 493 0.0036
381 MIDDLE INSOMNIA 67 0.0036
382 HEART RATE IRREGULAR 81 0.0036
383 BODY TEMPERATURE INCREASED 73 0.0036
384 SKIN HAEMORRHAGE 53 0.0036
385 MUSCULOSKELETAL DISORDER 68 0.0036
386 MUSCULOSKELETAL PAIN 187 0.0036
387 THYROID DISORDER 55 0.0036
388 DEFAECATION URGENCY 25 0.0036
389 BACK DISORDER 58 0.0036
390 TOOTH INFECTION 47 0.0036
391 JOINT SWELLING 429 0.0036
392 OSTEOPOROSIS 146 0.0035
393 PARAESTHESIA 558 0.0035
394 C-REACTIVE PROTEIN INCREASED 129 0.0035
395 HEPATIC STEATOSIS 66 0.0035
396 INTENTIONAL DOSE OMISSION 101 0.0035
397 ANOSMIA 51 0.0035
398 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
399 VIRAL INFECTION 116 0.0035
400 HYPOAESTHESIA 521 0.0035
401 CORONAVIRUS INFECTION 23 0.0035
402 BLOOD URINE PRESENT 66 0.0035
403 INSOMNIA 922 0.0035
404 VITREOUS FLOATERS 34 0.0035
405 ULCER 55 0.0035
406 PLATELET COUNT INCREASED 45 0.0034
407 GASTROINTESTINAL DISORDER 309 0.0034
408 FATIGUE 2685 0.0034
409 APHONIA 48 0.0034
410 NEPHROPATHY 32 0.0034
411 NEUROPATHY PERIPHERAL 326 0.0034
412 PAIN IN JAW 97 0.0034
413 HAEMOGLOBIN ABNORMAL 22 0.0034
414 IMMUNE SYSTEM DISORDER 45 0.0034
415 DRUG-INDUCED LIVER INJURY 107 0.0034
416 NASAL DISCOMFORT 27 0.0034
417 URINE ODOUR ABNORMAL 20 0.0034
418 BACK PAIN 790 0.0034
419 ULCER HAEMORRHAGE 23 0.0034
420 TRICUSPID VALVE INCOMPETENCE 27 0.0034
421 TEMPERATURE INTOLERANCE 35 0.0034
422 ATRIAL FLUTTER 27 0.0034
423 BLOOD PRESSURE INCREASED 516 0.0034
424 INFUSION SITE EXTRAVASATION 21 0.0034
425 ASTHENIA 1265 0.0034
426 PRODUCT SUPPLY ISSUE 24 0.0034
427 IMMUNODEFICIENCY 50 0.0034
428 DRY THROAT 34 0.0033
429 FRUSTRATION TOLERANCE DECREASED 27 0.0033
430 PELVIC FRACTURE 26 0.0033
431 BASAL CELL CARCINOMA 52 0.0033
432 HAIR GROWTH ABNORMAL 23 0.0033
433 DYSPHONIA 194 0.0033
434 PRODUCT DOSE OMISSION ISSUE 973 0.0033
435 FLANK PAIN 31 0.0033
436 CONTRAINDICATED PRODUCT ADMINISTERED 100 0.0033
437 GAIT DISTURBANCE 632 0.0033
438 POLYURIA 27 0.0033
439 HICCUPS 27 0.0033
440 BLOOD SODIUM DECREASED 62 0.0033
441 DYSURIA 121 0.0033
442 ARTHRALGIA 1363 0.0033
443 HYPOTENSION 657 0.0033
444 CHEST DISCOMFORT 335 0.0033
445 COLITIS 124 0.0033
446 PAIN 2007 0.0033
447 HYPERLIPIDAEMIA 39 0.0033
448 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
449 NERVE COMPRESSION 30 0.0032
450 HYPERSOMNIA 93 0.0032
451 DYSGEUSIA 241 0.0032
452 LACRIMATION INCREASED 98 0.0032
453 TINNITUS 149 0.0032
454 SENSORY DISTURBANCE 52 0.0032
455 CYSTITIS 103 0.0032
456 BONE PAIN 189 0.0032
457 INABILITY TO AFFORD MEDICATION 32 0.0032
458 NODULE 42 0.0032
459 HAIR TEXTURE ABNORMAL 43 0.0032
460 PRODUCT AVAILABILITY ISSUE 73 0.0032
461 DRUG INTOLERANCE 309 0.0032
462 BURNING SENSATION 224 0.0032
463 ROTATOR CUFF SYNDROME 41 0.0032
464 OEDEMA 173 0.0032
465 INTENTIONAL PRODUCT USE ISSUE 279 0.0032
466 AUTOIMMUNE DISORDER 31 0.0032
467 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54 0.0032
468 WEIGHT DECREASED 885 0.0032
469 CHILLS 371 0.0032
470 WHITE BLOOD CELL COUNT DECREASED 343 0.0032
471 RIB FRACTURE 65 0.0032
472 TRANSFUSION 33 0.0031
473 BODY TEMPERATURE DECREASED 31 0.0031
474 TOOTHACHE 57 0.0031
475 TOOTH DISORDER 70 0.0031
476 PHARYNGITIS STREPTOCOCCAL 34 0.0031
477 SKIN LESION 86 0.0031
478 WHITE BLOOD CELL COUNT ABNORMAL 20 0.0031
479 CONJUNCTIVITIS 58 0.0031
480 INCONTINENCE 33 0.0031
481 SKIN INFECTION 35 0.0031
482 HYSTERECTOMY 27 0.0031
483 ARTHRITIS 245 0.0031
484 MOVEMENT DISORDER 100 0.0031
485 LOCALISED INFECTION 75 0.0031
486 HYPOKINESIA 45 0.0031
487 CELLULITIS 156 0.0031
488 FEELING HOT 189 0.0031
489 SPLENOMEGALY 36 0.0031
490 POST PROCEDURAL COMPLICATION 59 0.0031
491 PRODUCT ADMINISTRATION ERROR 62 0.0031
492 TENDON DISORDER 20 0.0031
493 GASTROINTESTINAL INFLAMMATION 24 0.0031
494 VENTRICULAR FIBRILLATION 34 0.0031
495 NERVE INJURY 34 0.0031
496 NEPHROLITHIASIS 140 0.0030
497 EPISTAXIS 228 0.0030
498 HYPOGAMMAGLOBULINAEMIA 20 0.0030
499 PAIN IN EXTREMITY 895 0.0030
500 HOSPICE CARE 30 0.0030
501 HEADACHE 1903 0.0030
502 HEART RATE INCREASED 300 0.0030
503 PRODUCT SUBSTITUTION ISSUE 174 0.0030
504 GASTROINTESTINAL INFECTION 27 0.0030
505 DERMATITIS 63 0.0030
506 MYALGIA 511 0.0030
507 WEIGHT INCREASED 673 0.0030
508 ORAL DISORDER 22 0.0030
509 HERNIA 58 0.0030
510 TOOTH FRACTURE 33 0.0030
511 FLUID RETENTION 152 0.0030
512 QUALITY OF LIFE DECREASED 40 0.0030
513 ILL-DEFINED DISORDER 181 0.0030
514 DIARRHOEA 1922 0.0030
515 SKIN EXFOLIATION 251 0.0030
516 HYPOPHAGIA 76 0.0030
517 CONCUSSION 23 0.0030
518 BEDRIDDEN 39 0.0030
519 FEELING ABNORMAL 709 0.0030
520 SCRATCH 31 0.0029
521 LYMPHADENOPATHY 104 0.0029
522 INTERVERTEBRAL DISC PROTRUSION 64 0.0029
523 HAEMATOCRIT DECREASED 58 0.0029
524 BLOOD PRESSURE ABNORMAL 58 0.0029
525 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 207 0.0029
526 POOR VENOUS ACCESS 30 0.0029
527 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32 0.0029
528 LOSS OF LIBIDO 26 0.0029
529 EYE DISCHARGE 30 0.0029
530 BLOOD PRESSURE FLUCTUATION 69 0.0029
531 DECREASED APPETITE 667 0.0029
532 THERAPY INTERRUPTED 205 0.0029
533 OCULAR HYPERAEMIA 136 0.0029
534 ABDOMINAL PAIN UPPER 589 0.0029
535 URINE OUTPUT DECREASED 25 0.0029
536 FAECES DISCOLOURED 62 0.0029
537 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
538 RHINITIS 23 0.0028
539 SPINAL DISORDER 27 0.0028
540 DIVERTICULITIS 79 0.0028
541 SKIN DISCOLOURATION 131 0.0028
542 TOOTH ABSCESS 29 0.0028
543 THERAPY CESSATION 146 0.0028
544 INFLUENZA 317 0.0028
545 HERPES ZOSTER 163 0.0028
546 CHROMATURIA 64 0.0028
547 FEELING DRUNK 21 0.0028
548 ECZEMA 146 0.0028
549 VISION BLURRED 383 0.0028
550 CARDIOGENIC SHOCK 40 0.0028
551 BLOOD ALBUMIN DECREASED 22 0.0028
552 DYSPHAGIA 263 0.0028
553 EYE SWELLING 103 0.0028
554 SKIN SWELLING 24 0.0028
555 ARTERIOSCLEROSIS 26 0.0028
556 OSTEOMYELITIS 50 0.0028
557 FISTULA 31 0.0028
558 HYPERTENSION 582 0.0027
559 DIZZINESS 1370 0.0027
560 SPINAL FRACTURE 55 0.0027
561 RESPIRATORY DISORDER 82 0.0027
562 PULMONARY CONGESTION 36 0.0027
563 IMMUNOSUPPRESSION 24 0.0027
564 HEAD INJURY 86 0.0027
565 MUSCLE DISORDER 22 0.0027
566 CONFUSIONAL STATE 437 0.0027
567 END STAGE RENAL DISEASE 49 0.0027
568 CHOLELITHIASIS 88 0.0027
569 BLOOD PRESSURE DECREASED 178 0.0027
570 INCREASED APPETITE 51 0.0027
571 DYSPNOEA 1509 0.0027
572 HEPATIC CIRRHOSIS 50 0.0027
573 CLOSTRIDIUM DIFFICILE INFECTION 58 0.0027
574 DYSARTHRIA 100 0.0027
575 RECTAL HAEMORRHAGE 114 0.0027
576 DEMENTIA 74 0.0026
577 PNEUMONIA 857 0.0026
578 RHEUMATOID ARTHRITIS 300 0.0026
579 IMPAIRED DRIVING ABILITY 30 0.0026
580 PALPITATIONS 309 0.0026
581 TRANSIENT ISCHAEMIC ATTACK 89 0.0026
582 SPUTUM DISCOLOURED 25 0.0026
583 PRESYNCOPE 64 0.0026
584 SKIN ULCER 68 0.0026
585 THROAT TIGHTNESS 71 0.0026
586 GROIN PAIN 23 0.0026
587 PRURITUS 1003 0.0026
588 PANIC ATTACK 95 0.0026
589 CONDITION AGGRAVATED 792 0.0026
590 RASH PRURITIC 141 0.0026
591 COLITIS ULCERATIVE 116 0.0026
592 ORAL DISCOMFORT 36 0.0026
593 ERECTILE DYSFUNCTION 66 0.0026
594 PULMONARY THROMBOSIS 28 0.0026
595 GINGIVAL BLEEDING 35 0.0026
596 UPPER LIMB FRACTURE 51 0.0026
597 PULMONARY FIBROSIS 49 0.0026
598 SCHIZOPHRENIA 31 0.0025
599 LOWER LIMB FRACTURE 49 0.0025
600 KIDNEY INFECTION 50 0.0025
601 DEPRESSION 579 0.0025
602 RASH 1109 0.0025
603 PHOTOSENSITIVITY REACTION 42 0.0025
604 LABORATORY TEST ABNORMAL 75 0.0025
605 LETHARGY 146 0.0025
606 HAEMATOCHEZIA 140 0.0025
607 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 132 0.0025
608 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
609 DEHYDRATION 337 0.0025
610 ANKLE FRACTURE 39 0.0025
611 HIP FRACTURE 81 0.0025
612 FLUSHING 256 0.0025
613 NAUSEA 1991 0.0025
614 NIGHTMARE 87 0.0025
615 THERAPY NON-RESPONDER 113 0.0025
616 VERTIGO 153 0.0025
617 INFLUENZA LIKE ILLNESS 206 0.0025
618 DRUG EFFECT LESS THAN EXPECTED 37 0.0025
619 ACUTE RESPIRATORY FAILURE 48 0.0025
620 HYPERSENSITIVITY 463 0.0025
621 EYE DISORDER 82 0.0025
622 LIMB DISCOMFORT 77 0.0025
623 ABDOMINAL PAIN 576 0.0025
624 HAEMOPTYSIS 69 0.0025
625 APATHY 36 0.0025
626 HALLUCINATION 186 0.0025
627 INTENTIONAL PRODUCT MISUSE 216 0.0025
628 EYE IRRITATION 142 0.0025
629 DRY SKIN 329 0.0025
630 DIPLOPIA 64 0.0025
631 ASTHMA 278 0.0025
632 PRESCRIBED UNDERDOSE 49 0.0025
633 ASCITES 72 0.0024
634 SQUAMOUS CELL CARCINOMA 23 0.0024
635 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440 0.0024
636 BREAST PAIN 26 0.0024
637 SMALL INTESTINAL OBSTRUCTION 30 0.0024
638 MASS 34 0.0024
639 PLATELET COUNT DECREASED 259 0.0024
640 GENERALISED OEDEMA 30 0.0024
641 IMPAIRED GASTRIC EMPTYING 33 0.0024
642 HEART RATE DECREASED 85 0.0024
643 BONE DISORDER 44 0.0024
644 INTESTINAL OBSTRUCTION 91 0.0024
645 HYPOTHYROIDISM 77 0.0024
646 EYE INFLAMMATION 23 0.0024
647 PRODUCT USE IN UNAPPROVED INDICATION 596 0.0024
648 DEVICE RELATED INFECTION 37 0.0024
649 EATING DISORDER 51 0.0024
650 DISTURBANCE IN ATTENTION 129 0.0024
651 CHEST PAIN 442 0.0024
652 APHASIA 72 0.0024
653 RASH MACULAR 83 0.0024
654 OSTEOPENIA 36 0.0024
655 INFECTION 343 0.0024
656 THERAPEUTIC RESPONSE UNEXPECTED 106 0.0024
657 DISCOMFORT 144 0.0024
658 ATRIAL FIBRILLATION 229 0.0023
659 THROMBOSIS 188 0.0023
660 MOUTH ULCERATION 49 0.0023
661 RENAL DISORDER 108 0.0023
662 MYOPATHY 20 0.0023
663 URTICARIA 387 0.0023
664 DEPRESSED MOOD 122 0.0023
665 TREMOR 383 0.0023
666 CHOKING 45 0.0023
667 EMOTIONAL DISORDER 71 0.0023
668 SOMNOLENCE 462 0.0023
669 COORDINATION ABNORMAL 32 0.0023
670 IMPAIRED WORK ABILITY 49 0.0023
671 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
672 PRODUCT TASTE ABNORMAL 31 0.0023
673 HAEMOGLOBIN DECREASED 235 0.0023
674 CRYING 83 0.0023
675 PULMONARY MASS 34 0.0023
676 ANXIETY 649 0.0023
677 BLOOD POTASSIUM INCREASED 37 0.0023
678 VISUAL IMPAIRMENT 282 0.0023
679 MALAISE 998 0.0023
680 ROAD TRAFFIC ACCIDENT 95 0.0023
681 TENDON RUPTURE 28 0.0023
682 OEDEMA PERIPHERAL 276 0.0023
683 INJURY 159 0.0023
684 ACCIDENT 27 0.0023
685 PULMONARY HYPERTENSION 47 0.0023
686 CYST 28 0.0023
687 ANAEMIA 430 0.0023
688 HEPATOMEGALY 22 0.0022
689 ELECTROLYTE IMBALANCE 26 0.0022
690 SPEECH DISORDER 117 0.0022
691 LIVER DISORDER 99 0.0022
692 AMNESIA 145 0.0022
693 CATARACT 132 0.0022
694 VENTRICULAR EXTRASYSTOLES 23 0.0022
695 MITRAL VALVE INCOMPETENCE 25 0.0022
696 HAEMORRHOIDS 43 0.0022
697 DERMATITIS ATOPIC 116 0.0022
698 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
699 CHOLECYSTECTOMY 25 0.0022
700 INTERNAL HAEMORRHAGE 25 0.0022
701 HALLUCINATION, VISUAL 46 0.0022
702 PROSTATIC SPECIFIC ANTIGEN INCREASED 30 0.0022
703 PHARYNGITIS 27 0.0022
704 TOXICITY TO VARIOUS AGENTS 366 0.0022
705 MUSCLE TWITCHING 50 0.0022
706 MATERNAL EXPOSURE DURING PREGNANCY 193 0.0022
707 HYPOACUSIS 93 0.0022
708 FEELING JITTERY 41 0.0021
709 OFF LABEL USE 1871 0.0021
710 COMPLICATION ASSOCIATED WITH DEVICE 31 0.0021
711 SEXUAL DYSFUNCTION 25 0.0021
712 GALLBLADDER DISORDER 38 0.0021
713 ERYTHEMA 437 0.0021
714 VOMITING 998 0.0021
715 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
716 PAIN OF SKIN 57 0.0021
717 CORONARY ARTERY OCCLUSION 29 0.0021
718 DIABETES MELLITUS 161 0.0021
719 IRRITABILITY 127 0.0021
720 WHITE BLOOD CELL COUNT INCREASED 81 0.0021
721 INJECTION SITE REACTION 145 0.0021
722 OESOPHAGITIS 23 0.0021
723 BRAIN INJURY 21 0.0021
724 HAIR COLOUR CHANGES 26 0.0021
725 LOSS OF CONSCIOUSNESS 266 0.0021
726 PYREXIA 717 0.0021
727 ABSCESS 33 0.0021
728 HYPERHIDROSIS 266 0.0021
729 STAPHYLOCOCCAL INFECTION 68 0.0021
730 FOOT FRACTURE 39 0.0021
731 SWOLLEN TONGUE 64 0.0020
732 BLOOD COUNT ABNORMAL 31 0.0020
733 COLD SWEAT 36 0.0020
734 DYSKINESIA 83 0.0020
735 GENERAL PHYSICAL HEALTH DETERIORATION 236 0.0020
736 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
737 SPINAL OPERATION 25 0.0020
738 BACTERAEMIA 24 0.0020
739 CHRONIC KIDNEY DISEASE 153 0.0020
740 PETECHIAE 21 0.0020
741 HUNGER 28 0.0020
742 SEIZURE 232 0.0020
743 DISORIENTATION 79 0.0020
744 CORONARY ARTERY DISEASE 60 0.0020
745 LYMPHOCYTE COUNT DECREASED 35 0.0020
746 MOOD SWINGS 63 0.0020
747 DISABILITY 39 0.0020
748 NERVOUSNESS 103 0.0020
749 INJECTION SITE BRUISING 157 0.0020
750 HIP ARTHROPLASTY 30 0.0020
751 SKIN CANCER 42 0.0019
752 SWELLING FACE 127 0.0019
753 MENTAL IMPAIRMENT 47 0.0019
754 GASTRITIS 51 0.0019
755 SEPSIS 216 0.0019
756 EYE PRURITUS 65 0.0019
757 SEROTONIN SYNDROME 37 0.0019
758 BLOOD TRIGLYCERIDES INCREASED 34 0.0019
759 MUSCLE RIGIDITY 23 0.0019
760 GLAUCOMA 37 0.0019
761 BLOOD UREA INCREASED 32 0.0019
762 MENTAL STATUS CHANGES 53 0.0019
763 HAEMATURIA 65 0.0019
764 ADRENAL INSUFFICIENCY 23 0.0019
765 ANGER 64 0.0019
766 JOINT DISLOCATION 20 0.0019
767 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
768 DELUSION 29 0.0019
769 MALIGNANT MELANOMA 25 0.0019
770 MULTIPLE SCLEROSIS 89 0.0019
771 THERAPY PARTIAL RESPONDER 29 0.0019
772 URINARY RETENTION 62 0.0019
773 TOOTH EXTRACTION 23 0.0018
774 ECONOMIC PROBLEM 28 0.0018
775 ABNORMAL DREAMS 51 0.0018
776 CHOLECYSTITIS 22 0.0018
777 UVEITIS 25 0.0018
778 MOOD ALTERED 50 0.0018
779 PNEUMOTHORAX 29 0.0018
780 ACTIVITIES OF DAILY LIVING IMPAIRED 36 0.0018
781 PARALYSIS 26 0.0018
782 VASCULITIS 21 0.0018
783 DRUG ABUSE 150 0.0018
784 PLEURAL EFFUSION 109 0.0018
785 CARDIOMEGALY 22 0.0018
786 PRODUCT USE ISSUE 335 0.0018
787 REBOUND EFFECT 20 0.0018
788 WITHDRAWAL SYNDROME 74 0.0018
789 TREATMENT FAILURE 146 0.0018
790 BLOOD CREATININE INCREASED 115 0.0018
791 RASH ERYTHEMATOUS 84 0.0018
792 NEOPLASM PROGRESSION 61 0.0018
793 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96 0.0017
794 SUICIDAL IDEATION 160 0.0017
795 SEPTIC SHOCK 76 0.0017
796 ABDOMINAL PAIN LOWER 44 0.0017
797 GASTRIC ULCER 33 0.0017
798 ADVERSE DRUG REACTION 155 0.0017
799 MENTAL DISORDER 75 0.0017
800 FOETAL EXPOSURE DURING PREGNANCY 140 0.0017
801 EXPOSURE DURING PREGNANCY 107 0.0017
802 UNEVALUABLE EVENT 130 0.0017
803 POST PROCEDURAL HAEMORRHAGE 20 0.0017
804 CYANOSIS 27 0.0017
805 SYNCOPE 171 0.0017
806 SURGERY 100 0.0017
807 NERVOUS SYSTEM DISORDER 53 0.0017
808 PNEUMONITIS 46 0.0017
809 DRUG INTERACTION 267 0.0017
810 DEAFNESS 44 0.0017
811 INJECTION SITE DISCOLOURATION 21 0.0017
812 PRODUCT PRESCRIBING ERROR 40 0.0017
813 ASPARTATE AMINOTRANSFERASE INCREASED 89 0.0017
814 ANGINA PECTORIS 48 0.0017
815 FEAR 45 0.0017
816 INJECTION SITE SWELLING 128 0.0017
817 CARDIAC DISORDER 156 0.0017
818 UNDERDOSE 121 0.0017
819 LIP SWELLING 55 0.0016
820 PELVIC PAIN 30 0.0016
821 CYTOPENIA 20 0.0016
822 PARANOIA 28 0.0016
823 INJECTION SITE PAIN 498 0.0016
824 NEUTROPHIL COUNT DECREASED 66 0.0016
825 HYPOXIA 57 0.0016
826 LYMPHOMA 25 0.0016
827 RENAL FAILURE 214 0.0016
828 ANHEDONIA 42 0.0016
829 HYPONATRAEMIA 90 0.0016
830 HEMIPARESIS 27 0.0016
831 INTERSTITIAL LUNG DISEASE 77 0.0016
832 APPLICATION SITE PAIN 35 0.0016
833 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
834 PULMONARY OEDEMA 71 0.0016
835 PSORIASIS 207 0.0016
836 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
837 INJECTION SITE PRURITUS 106 0.0016
838 MANIA 26 0.0016
839 EYE HAEMORRHAGE 21 0.0016
840 PHARYNGEAL OEDEMA 24 0.0016
841 CARDIAC FAILURE CONGESTIVE 125 0.0016
842 LEUKOCYTOSIS 28 0.0015
843 RESPIRATORY DISTRESS 42 0.0015
844 TREATMENT NONCOMPLIANCE 83 0.0015
845 RASH PAPULAR 34 0.0015
846 MULTIPLE SCLEROSIS RELAPSE 103 0.0015
847 INJECTION SITE ERYTHEMA 186 0.0015
848 PRESCRIBED OVERDOSE 29 0.0015
849 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
850 PULMONARY EMBOLISM 142 0.0015
851 HAEMORRHAGE 156 0.0015
852 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
853 MUCOSAL INFLAMMATION 39 0.0015
854 PLASMA CELL MYELOMA 58 0.0015
855 JAUNDICE 40 0.0015
856 GASTRIC DISORDER 51 0.0015
857 FEMUR FRACTURE 46 0.0015
858 BRONCHOSPASM 21 0.0015
859 PALLOR 40 0.0015
860 PRODUCT PRESCRIBING ISSUE 32 0.0015
861 BONE DENSITY DECREASED 46 0.0015
862 EXPOSURE VIA SKIN CONTACT 38 0.0015
863 THERAPEUTIC RESPONSE DECREASED 88 0.0014
864 EXPIRED PRODUCT ADMINISTERED 48 0.0014
865 NEEDLE ISSUE 42 0.0014
866 PRODUCT PHYSICAL ISSUE 29 0.0014
867 INJECTION SITE MASS 53 0.0014
868 PANCYTOPENIA 80 0.0014
869 TACHYCARDIA 127 0.0014
870 DEVICE USE ISSUE 25 0.0014
871 INJECTION SITE HAEMORRHAGE 112 0.0014
872 INJECTION SITE RASH 43 0.0014
873 PRODUCT QUALITY ISSUE 190 0.0014
874 BLOOD GLUCOSE DECREASED 67 0.0014
875 RESTLESSNESS 51 0.0014
876 HAEMATOMA 36 0.0014
877 DEEP VEIN THROMBOSIS 90 0.0014
878 VAGINAL HAEMORRHAGE 60 0.0014
879 COAGULOPATHY 23 0.0014
880 APPLICATION SITE PRURITUS 31 0.0014
881 AGITATION 100 0.0014
882 DEVICE ISSUE 121 0.0013
883 METASTASES TO BONE 22 0.0013
884 LUNG NEOPLASM MALIGNANT 55 0.0013
885 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
886 BRADYCARDIA 69 0.0013
887 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
888 RENAL IMPAIRMENT 109 0.0013
889 DYSTONIA 25 0.0013
890 OVERDOSE 278 0.0013
891 NEOPLASM MALIGNANT 86 0.0013
892 FEBRILE NEUTROPENIA 85 0.0013
893 LIVER FUNCTION TEST ABNORMAL 37 0.0013
894 ACNE 96 0.0013
895 ABNORMAL BEHAVIOUR 50 0.0013
896 DISEASE PROGRESSION 149 0.0013
897 HOSPITALISATION 193 0.0013
898 PRURITUS GENERALISED 27 0.0012
899 DRUG INEFFECTIVE 1640 0.0012
900 INCORRECT DOSE ADMINISTERED 284 0.0012
901 PRODUCT PREPARATION ERROR 25 0.0012
902 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 246 0.0012
903 VENTRICULAR TACHYCARDIA 20 0.0012
904 DELIRIUM 42 0.0012
905 EXTRA DOSE ADMINISTERED 49 0.0012
906 SKIN BURNING SENSATION 86 0.0012
907 BLOOD GLUCOSE ABNORMAL 22 0.0012
908 BLOOD BILIRUBIN INCREASED 32 0.0012
909 CEREBRAL HAEMORRHAGE 42 0.0012
910 PERICARDIAL EFFUSION 27 0.0012
911 UNRESPONSIVE TO STIMULI 30 0.0012
912 PNEUMONIA ASPIRATION 29 0.0012
913 AGGRESSION 58 0.0012
914 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 27 0.0012
915 BLINDNESS 47 0.0012
916 BLOOD GLUCOSE INCREASED 217 0.0012
917 APPLICATION SITE ERYTHEMA 30 0.0011
918 ANAPHYLACTIC REACTION 63 0.0011
919 SHOCK 26 0.0011
920 ACUTE KIDNEY INJURY 173 0.0011
921 HEPATIC FAILURE 34 0.0011
922 TOOTH LOSS 23 0.0011
923 INJECTION SITE URTICARIA 27 0.0011
924 PANCREATITIS 58 0.0011
925 CARDIAC FAILURE 88 0.0011
926 AMENORRHOEA 19 0.0011
927 HYPOKALAEMIA 50 0.0011
928 DEVICE DISLOCATION 47 0.0011
929 PRODUCT COMPLAINT 27 0.0011
930 MALIGNANT NEOPLASM PROGRESSION 109 0.0011
931 CEREBROVASCULAR ACCIDENT 176 0.0010
932 ARRHYTHMIA 49 0.0010
933 HYPERKALAEMIA 36 0.0010
934 SKIN IRRITATION 47 0.0010
935 INJECTION SITE WARMTH 21 0.0010
936 GASTROINTESTINAL HAEMORRHAGE 83 0.0010
937 MEDICATION ERROR 55 0.0010
938 ABASIA 24 0.0010
939 HYPOGLYCAEMIA 47 0.0010
940 RESPIRATORY FAILURE 69 0.0009
941 DRUG ADMINISTRATION ERROR 29 0.0009
942 CARDIAC ARREST 78 0.0009
943 ADVERSE EVENT 87 0.0009
944 ENCEPHALOPATHY 23 0.0009
945 PANCREATITIS ACUTE 21 0.0009
946 DEVICE MALFUNCTION 65 0.0009
947 PSYCHOTIC DISORDER 27 0.0009
948 RHABDOMYOLYSIS 38 0.0009
949 HEPATOTOXICITY 20 0.0009
950 OSTEONECROSIS OF JAW 22 0.0009
951 HYPERGLYCAEMIA 32 0.0009
952 THROMBOCYTOPENIA 98 0.0009
953 NEUTROPENIA 118 0.0009
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 40 0.0009
955 INCORRECT DRUG ADMINISTRATION DURATION 24 0.0009
956 OSTEONECROSIS 28 0.0009
957 HAEMATEMESIS 21 0.0008
958 PRODUCT DOSE OMISSION 54 0.0008
959 DRUG EFFECT INCOMPLETE 30 0.0008
960 MYOCARDIAL INFARCTION 144 0.0008
961 RENAL FAILURE ACUTE 35 0.0008
962 METABOLIC ACIDOSIS 26 0.0008
963 VISUAL ACUITY REDUCED 27 0.0008
964 INCORRECT DOSE ADMINISTERED BY DEVICE 21 0.0008
965 PREMATURE BABY 24 0.0008
966 EMOTIONAL DISTRESS 95 0.0008
967 DEVICE LEAKAGE 34 0.0008
968 TARDIVE DYSKINESIA 22 0.0008
969 RESPIRATORY ARREST 21 0.0008
970 DRUG EFFECT DECREASED 41 0.0008
971 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22 0.0008
972 ACCIDENTAL EXPOSURE TO PRODUCT 77 0.0007
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
974 DEATH 617 0.0007
975 ACUTE MYOCARDIAL INFARCTION 21 0.0007
976 ACCIDENTAL OVERDOSE 26 0.0007
977 LEUKOPENIA 35 0.0007
978 HEPATIC FUNCTION ABNORMAL 25 0.0007
979 DEVICE BREAKAGE 27 0.0007
980 CONVULSION 37 0.0006
981 DRUG DOSE OMISSION 106 0.0006
982 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
983 PRODUCT STORAGE ERROR 53 0.0006
984 BREAST CANCER 56 0.0006
985 CARDIO-RESPIRATORY ARREST 24 0.0006
986 DEVICE DIFFICULT TO USE 35 0.0005
987 DRUG WITHDRAWAL SYNDROME 44 0.0005
988 DRUG DEPENDENCE 76 0.0005
989 NO ADVERSE EVENT 73 0.0004
990 SUICIDE ATTEMPT 24 0.0004
991 DRUG DOSE OMISSION BY DEVICE 24 0.0003
992 PROSTATE CANCER 21 0.0003